UBS Initiates CoreWeave at Buy on Same Day as Multi-Year Compute Contract with Harell Data Announced
nashnova research
UBS initiated coverage of CoreWeave with a Buy rating and a $120 price target, implying 38% upside; the same day, CoreWeave landed a multi-year compute contract with Harell Data — together, the two moves directly address the market's core doubt: whether demand for its GPU cloud is real enough to justify the leverage.
Why does UBS call Buy after an 18% drop?
CoreWeave shares have fallen nearly 18% over three months, pressured by concerns over high leverage and a $3 billion convertible-bond offering plus a share sale that raised dilution fears.
UBS analyst Karl Keirstead acknowledged that "the easier path would have been to initiate at neutral and wait" — yet UBS chose to go Buy.
This means → UBS believes the leverage worry has neared its peak; downside pressure is limited, while upside elasticity is underpriced.
What does UBS see that the market is missing?
Argument one: AI compute demand extends well beyond frontier labs — enterprise adoption is accelerating, and the breadth of demand is underestimated.
Argument two: GPU pricing trends should push revenue per gigawatt from roughly $11 billion today toward $15 billion-plus over time.
In plain terms = UBS sees a volume-and-price story — the unit price CoreWeave charges for compute is rising, while the pool of buyers keeps widening.
What does the Harell Data contract signal?
Announced the same day: AI data firm Harell Data will run model training, fine-tuning, and inference workloads on CoreWeave's cloud platform.
Harell Data provides proprietary scientific datasets for AI model development — this is an independent enterprise customer, not an in-house big-tech project.
This means → the contract gives UBS's "enterprise demand is accelerating" thesis a concrete, customer-side proof point, moving it beyond analyst forecasting.
Where does the Street stand — and what's still at risk?
Per LSEG data, 28 out of 41 analysts covering CoreWeave rate it Buy or Strong Buy — the consensus direction aligns with UBS.
The unresolved core risk remains leverage: a $3 billion convertible-bond issue plus new share issuance creates real dilution pressure.
In plain terms = most analysts like the direction, but this company is essentially borrowing to bet that demand keeps growing — if AI compute demand slows, high leverage flips from accelerator to noose.
市场有风险，内容仅供研究参考，不构成投资建议。